Related Experiment Video
Updated: Sep 24, 2025
09:36
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
2.9K
Pediatric Acute Respiratory Distress Syndrome in COVID-19 Pandemic: Is it the Puzzle of the Century?
Rohit Bhowmick1, Krishna M Gulla2
1Department of Pediatrics, All India Institute of Medical Sciences, Kalyani, West Bengal, India.
Insights
The COVID-19 pandemic presented a significant challenge in diagnosing Pediatric Acute Respiratory Distress Syndrome (PARDS). Further research is crucial to understand and manage this complex pediatric critical care condition.
Area of Science:
- Critical Care Medicine
- Pediatric Pulmonology
- Infectious Diseases
Background:
- The COVID-19 pandemic introduced unique challenges in pediatric critical care, particularly concerning respiratory illnesses.
- Pediatric Acute Respiratory Distress Syndrome (PARDS) emerged as a complex condition during the pandemic, necessitating a deeper understanding of its presentation and management in children.
Discussion:
- The clinical presentation of PARDS in children during the COVID-19 pandemic was often atypical, complicating early diagnosis and treatment.
- Distinguishing COVID-19-related PARDS from other pediatric respiratory distress conditions required careful clinical evaluation and diagnostic strategies.
Key Insights:
- The pandemic highlighted the need for updated diagnostic criteria and management protocols for PARDS in pediatric populations.
- Understanding the specific pathophysiology and clinical course of COVID-19-associated PARDS is essential for improving patient outcomes.
Outlook:
- Future research should focus on long-term outcomes of children with COVID-19-related PARDS and the development of targeted therapies.
- Enhanced global collaboration and data sharing are vital for addressing the complexities of pediatric respiratory infections in pandemic scenarios.
Abstract:
Bhowmick R, Gulla KM. Pediatric Acute Respiratory Distress Syndrome in COVID-19 Pandemic: Is it the Puzzle of the Century? Indian J Crit Care Med 2022;26(3):264-265.
More Related Videos
Related Concept Videos
01:23Acute Respiratory Failure-IV
254
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
254
01:21Acute Respiratory Failure-I
364
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
364
01:21Acute Respiratory Failure-II
403
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
403
01:29Acute Respiratory Failure-V
219
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
219
01:30Acute Respiratory Failure-III
358
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
358
01:17Pulmonary Cycle: Exhalation
1.8K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.8K